ProBiotex

ProBiotex is a South Korean biotechnology company, functioning as a specialized subsidiary of Bioneer Corporation, that focuses on the research and development of functional probiotics and microbiome-based therapeutics. The company gained international recognition for its discovery and development of Lactobacillus gasseri BNR17, a proprietary probiotic strain that has received regulatory approval in multiple jurisdictions for its role in body fat reduction and weight management. ProBiotex utilizes advanced microbial fermentation and screening platforms to identify strains that address metabolic disorders, gut health, and immune system modulation. Its business model includes the production of high-stability probiotic raw materials and the development of live biotherapeutic products (LBPs) for clinical applications. The company’s flagship strain is licensed to various global partners for inclusion in functional foods and dietary supplements.